4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-058570
Chief Executive Officer gave up 741 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2019-12-01 | Shares withheld for taxes | −741 | $71.65 | $53,093 | 164,320 | D |
Loading xslF345X03/doc4.xml…